Quantum Biopharma Ltd. Class B Subordinate Voting Shares (QNTM) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Quantum Biopharma Ltd. Class B Subordinate Voting Shares (QNTM) is Strong Underperform.

The composite score behind that read is -0.57, weighing +0.00 of bullish evidence against -0.56 bearish.

Quantum Biopharma Ltd. Class B Subordinate Voting Shares last closed at $3.09, -5.50% on the session.

Against the IVW growth benchmark the position is -6.11% over the forecast window.

The read is built from 11 underlying insights — 0 bullish and 11 bearish.

Agreement across those insights is 100%.

17 graded predictions for QNTM so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Quantum Biopharma Ltd. Class B Subordinate Voting Shares in the 2nd percentile on return on equity, where 100 is best.

Quantum Biopharma Ltd. Class B Subordinate Voting Shares is classified under Health Care / Pharmaceuticals, with a market capitalisation of $26.91M.

StockMap tracks Quantum Biopharma Ltd. Class B Subordinate Voting Shares as the 112th largest of the 142 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 61 Moderate Underperform, 57 Neutral, 19 Strong Underperform and 5 Moderate Outperform.

On that composite Quantum Biopharma Ltd. Class B Subordinate Voting Shares ranks 135th of 142 in the group, against a group median of -0.24.